About Sāscan
Sāscan is a company based in Thiruvananthapuram (India) founded in 2015 by Subhash Narayanan. Sāscan has raised $339.5 thousand across 6 funding rounds from investors including Unicorn India Ventures, KIIT Technology Business Incubator and Startup Karnataka. Sāscan offers products and services including OralScan, CerviScan, Curelite, CureLaze, and OralView. Sāscan operates in a competitive market with competitors including Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others.
- Headquarter Thiruvananthapuram, India
- Founders Subhash Narayanan
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sascan.in
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Sascan Meditech Private Limited
- Date of Incorporation 14 Jul, 2015
- Jurisdiction Thiruvananthapuram, Kerala, India
- Annual Revenue₹1.52 Cr
FY 2025 · +26% YoY
- Net Loss-₹33.5 Lakh
FY 2025 · -22% margin
- EBITDA-₹27.4 Lakh
FY 2025 · -18% margin
- Total Equity Funding$339.5K (USD)
in 6 rounds
- InvestorsUnicorn India Ventures
& 5 more
Associated legal entities of Sāscan
Sāscan operates through Sascan Meditech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sascan Meditech Private Limited CIN U33110KL2015PTC068448 | Active | 14 Jul 2015 | Thiruvananthapuram, Kerala | ₹1.5 Cr | – | 2 | View details |
Products & Services of Sāscan
Sāscan offers a comprehensive portfolio of products and services, including OralScan, CerviScan, Curelite, CureLaze, and OralView.
Device for early oral cancer detection using multispectral imaging.
Tool for cervical cancer screening with advanced imaging technology.
Light-based therapy for wellness and tissue treatment.
Laser device for medical applications in cancer care.
Imaging system for real-time oral tissue analysis.
Apps and channels of Sāscan
its YouTube channel Sascan Meditech has 12 subscribers and 3 videos.
Videos from Sāscan
The most watched videos on Sāscan's YouTube channel, Sascan Meditech (12 subscribers). Click a video to play it here.
More on Sascan Meditech.
Funding Insights of Sāscan
Sāscan has successfully raised a total of $339.5K across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $339,498
- Total Rounds 6
- Investors Count 6
All 6 funding rounds of Sāscan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | – | Seed | – | – | |
| Apr 2021 | $133,268 | Seed | $1.14M | Usha Subhash | |
| Dec 2020 | $4,056 | Grant | – | – | |
| May 2020 | $132,615 | Seed | $997,718 | Unicorn India Ventures | – |
| May 2018 | $73,615 | Seed | $••••• | KIIT Technology Business Incubator, TIMed | – |
| Aug 2017 | – | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2021 | $1.14M | •••••••• |
Last known valuation $1.14M (Apr 2021). 6 investors in total: 5 institutional and 1 angel.
Investors in Sāscan
Sāscan has secured backing from 6 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Unicorn India Ventures, KIIT Technology Business Incubator and Startup Karnataka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering seed funding and support to startups in technology and innovation sectors. | 2014 | unicornivc.com | Mumbai, India | |
Startups incubator by KIIT University | – | kiitincubator.in | Bhubaneswar, India | |
Medical devices and biomaterials incubation services in India. | 2015 | timed.org.in | Thiruvananthapuram, India | |
- | – | winfoundations.org | - | |
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
US Usha Subhash | - | – | unknown_cb8e8900a95a4bf2a | - |
Investor details for Sāscan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sascan Meditech Private Limited (Sāscan)
Sascan Meditech Private Limited is the primary company behind Sāscan. The board of Sascan Meditech Private Limited currently have 2 directors; the longest-serving is Subhash Narayanan, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhash Narayanan DIN 06606351 | Director | 14 Jul 2015 | 11 yrs 2 mo | Sascan Meditech Private Limited |
| Usha Subhash DIN 07568028 | Director | 16 Jul 2016 | 10 yrs 2 mo | Sascan Meditech Private Limited |
People of Sāscan
1 people are tracked at Sāscan (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership |
Complete people profiles for Sāscan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sāscan
Figures of Sascan Meditech Private Limited, the primary company behind Sāscan, for FY 2025. Revenue was ₹1.52 Cr (+26% year on year). Net loss was -₹33.5 Lakh (-22% margin). EBITDA was -₹27.4 Lakh (-18% margin). Revenue has grown at a compounded annual rate of +13% over three years and +128% over five years.
- ₹1.52 CrRevenue · FY 2025 · +26% YoY
- -₹33.5 LakhNet loss · -22% margin
- -₹27.4 LakhEBITDA · -18% margin
- ₹9.3 LakhPaid-up capital
- +13%Revenue CAGR, 3 years
- +128%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sascan Meditech Private Limited are on its company page.
Detailed financial statements for Sāscan
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Sāscan
4 dated milestones of Sāscan across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Sāscan is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed,.
Competitors of Sāscan
Sāscan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| scholarrock.com | 2012 | Cambridge, United States | $103.3M | 150 | Antibody-based drugs for primary myopathies are developed and targeted. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | – | Microfluidics-based tools for cellular analysis are provided. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| samantree.com | 2014 | Lausanne, Switzerland | $33.78M | – | A surgical digital microscope for tumor resection is developed. | |
| phasefocus.com | 2006 | Sheffield, United Kingdom | $12.08M | 10 | Provider of virtual lens that generates High definition images without high-quality lenses | |
| perfinthealthcare.com | 2005 | Chennai, India | $41.48M | 36 | Solutions for image-guided interventional procedures are developed. | |
| lightpointmedical.com | 2012 | Rickmansworth, United Kingdom | $25.33M | 19 | Intraoperative imaging devices for real-time cancer detection are developed. | |
| nanovery.co.uk | 2018 | London, United Kingdom | $2.12M | 1 | Nanobots are developed for cancer diagnosis through bloodstream administration. | |
| dynamxmedical.com | 2015 | Didcot, United Kingdom | $40,000 | 7 | Biopsy screening devices for cancer and disease diagnosis are developed. |
Detailed competitors of Sāscan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sāscan
The website of Sāscan (sascan.in) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 3.5% vs previous month
Latest news on Sāscan
Complete news archive for Sāscan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sāscan
10 companies that operate in the same segment as Sāscan (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sāscan
Sāscan was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Sāscan is headquartered in Thiruvananthapuram, India. It is registered at Thiruvananthapuram, Kerala, India.
Subhash Narayanan is the current CEO of Sāscan. They have also founded this company.
Sāscan is a funded company, having raised a total of $339.5K across 6 funding rounds to date.
The primary company behind Sāscan, Sascan Meditech Private Limited, reported revenue of ₹1.52 Cr for FY 2025, up 26% year on year.
Sāscan was founded in 2015 in Thiruvananthapuram, India, within the medical devices sector. Focus is placed on biophotonics and related technologies for detecting early tissue abnormalities and malignancy. Operations involve the creation of devices such as OralScan for oral cavity lesion identification and CerviScan for cervical screening. Activities are centered on non-invasive diagnostic tools to support healthcare in oncology.
Sāscan's top competitors include Scholar Rock, Ionpath and SamanTree Medical.
Sāscan offers OralScan, CerviScan, Curelite, CureLaze, and OralView.
Sāscan has 6 investors. Key investors include Unicorn India Ventures, KIIT Technology Business Incubator, Startup Karnataka, TIMed, and Usha Subhash.
The valuation of Sāscan is $1.14M as of Apr 2021.
Sāscan operates through Sascan Meditech Private Limited.
The legal entities of Sāscan currently have 2 directors, including Subhash Narayanan, Usha Subhash.